![logo](/logos/NXS.AX.webp)
Next Science Limited
ASX:NXS.AX
0.2 (AUD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Next Science Limited |
Symbool | NXS.AX |
Munteenheid | AUD |
Prijs | 0.2 |
Beurswaarde | 58,432,000 |
Dividendpercentage | 0% |
52-weken bereik | 0.18 - 0.5 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Harry Thomas Hall |
Website | https://www.nextscience.com |
An error occurred while fetching data.
Over Next Science Limited
Next Science Limited, a medical technology company, researches, develops, and commercializes technologies that address the impacts of biofilms in human health in the United States and Australia. The company develops its products using Xbio Technology platform. It offers SURGX, an antimicrobial gel designed for surgical infection management; BACTISURE, a wound
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (AUD)
Cijfers zijn in miljoenen (AUD)